The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...
Read MoreA single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
Read MoreThe Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.
Read MoreDr. Edward Pham receives his MD and Ph.D in Microbiology & Immunology from Stanford University.
His research focus is on novel antiviral therapies for current and emerging viral infections and the relationship between chronic viral infection and cancer including liver cancer through studying how the innate and adaptive immune system are perturbed in chronic viral infection.
He has been recognized by many prestigious awards such as National Research Service Fellowship from NIH for MD/PhD, Gates Millenium Scholar, Howard Hughes Medical Institute, International Achievement Summit Delegate.